• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Biotechnology’s Role in Improving Stroke Outcomes

    CEO Spotlight: Marc Kikuchi

    Newsmakers: Darren Shirley

    Are You Prepared for the 2023 DSCSA Deadline?

    Rethinking the Changing Role of the CRO
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    AskBio Appoints Clinical Ops Executives

    SpectrumX Partners With UK Contract Manufacturer

    GL Chemtec Partners with Edgewater Capital to Accelerate Growth

    Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership

    Almac Invests $65M to Expand North American HQ
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    SpectrumX Partners With UK Contract Manufacturer

    Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership

    Almac Invests $65M to Expand North American HQ

    Captor Therapeutics Selects CDMO for Clinical Trial Materials

    Catalent to Acquire Metrics Contract Services for $475M
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    UPS to Acquire Healthcare Logistics Provider Bomi Group

    Marken to Acquire Medical Courier Business of Cedra Express

    5 Key Features of Agile Pharmaceutical Packaging Supply Chains That Drive Results

    Novavax Expands Manufacturing Agreement with SK bioscience

    Lonza Continues to Lead the Market with Innovative Hard Empty Capsules
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    GL Chemtec Partners with Edgewater Capital to Accelerate Growth

    West Pharmaceutical Makes Strategic Investment in Latch Medical

    “3 Key Trends” with James Park

    Captor Therapeutics Selects CDMO for Clinical Trial Materials

    Behind Every Successful eCOA Solution is a Robust Scientific Strategy
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Chime Biologics Receives Commercial Manufacturing License

    Automation Is Key to Meeting Demands in Pharmacovigilance

    UBC Acquires Examoto

    Responding to Consumer Complaints While Working with CMOs

    WuXi Vaccines Receives GMP Certificate from HPRA
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Kyongbo Pharmaceutical

    Quotient Sciences

    CMC Pharmaceuticals

    Vector Partners Limited
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Aphena Pharma Solutions

    Kyongbo Pharmaceutical

    Quotient Sciences

    CMC Pharmaceuticals

    Vector Partners Limited
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Maintaining Critical Drug Supply During the Pandemic

    Vin Colicchio from Dr. Reddy’s talks about the challenges and solutions of maintaining supply during the pandemic.

    Maintaining Critical Drug Supply During the Pandemic
    Related CONTENT
    • Bora Pharmaceuticals
    • Legacy Pharma Solutions
    • Taros Chemicals GmbH & Co. KG
    • Vio Chemicals
    • W. R. Grace FCMS
    Tim Wright, Editor, Contract Pharma06.17.21
    Prior to 2020, historically low-cost manufacturing, with just-in-time production and logistics, was key to staying competitive. In a time of crisis, however, the consequences of this model have become all too apparent. The leadership team at Dr. Reddy's rose to the challenge by adapting quickly, decisively and without hesitation. Identifying opportunities for improvement in supply and building new digital infrastructure helped the company deliver on their promises to customers and established a framework for the new normal. Vin Colicchio discusses the challenges and solutions of maintaining drug supply during the COVID crisis, and how the pandemic has changed the company's business model.
     
    Contract Pharma: How has Dr. Reddy’s coped with supply chain interference from the pandemic?
     
    Vincent Colicchio: Dr. Reddy’s approached the pandemic with the same patient-centric philosophy to continue supplying products as quickly as possible to avoid any supply gaps. We focused on our two priorities to help communities in India and around the world:
     
    1. Safety of our people and their families
    2. Produce and supply medicines to our patients and customers
     
    The situation was to meet the challenge of manufacturing and product supply from Dr. Reddy’s India production sites in addition to our network of contract manufacturing organizations (CMOs) and contract packaging organizations (CPOs)—all affected by COVID-19.
     
    We needed to prevent high absenteeism rates for production staff at our production sites to maximize output. To that end, Dr. Reddy’s ensured that its manufacturing sites utilized constant sanitization procedures for the staff and the facilities to maintain the health and safety of our people. We also arranged shuttle buses to take people back and forth to work and provided meals to people.
     
    Immediate actions taken to ensure supply meant that the outbound logistics played a critical role to ship products from our Dr. Reddy’s India manufacturing sites from Hyderabad to North America. These products were shipped to our third party logistics (3PL) providers in the U.S. and to U.S.-based CPOs. Strong competition for outbound air freight carriers from India to the U.S. meant that Dr. Reddy’s prioritized and secured flights and sea shipments every week. Commercial airlines were converted to cargo freighters once commercial air travel stalled. Our logistics and supply chain teams met every day for several months to coordinate demand and shipment priorities.
     
    The supply planning teams worked with global manufacturing, CMOs and CPOs to increase finished goods product volumes wherever applicable. The procurement teams evaluated all of the active pharmaceutical ingredients (APIs) and key starting aterials (KSMs) volumes which were in stock and for those where full supplies were unavailable. Strategies were developed with our partners to reinforce the supply of these materials. 
     
    Dr. Reddy’s also leveraged technology for communication and business operations. This was key for aligning all the teams at all times on any given day. This was through MS teams or Zoom. Flexibility with schedules was also important.
     
    The various cross functional teams worked 24/7 to work throughout the pandemic and this included the launch of several new products throughout 2020.
     
    CP: Have some medications been affected more than others, and what can be done about uneven supplies?
     
    VC: It is important to note that the majority of Dr Reddy’s products were in sufficient supply. The goal during the early days of the pandemic was to stabilize the supply output at our Dr. Reddy’s manufacturing sites and at the CMOs and CPOs to avoid disruptions for our customers. Early on, it was apparent that a few KSMs from China were in short supply. This impacted the manufacturing of a small number of API’s and finished products. Our procurement and external manufacturing teams worked closely with our partners to identify the gaps, implement the action plans to procure the materials and eventually resume production. 
     
    The key is to have in place a sufficient supply of APIs and raw materials to meet our production demands. Maintaining a high safety stock of critical APIs and other materials is imperative. Many pharma manufacturers and CMOs maintain only two to three months of API supplies and other critical materials on hand. They need to consider increasing the inventory levels to four to six months. Even though the investment is higher, the ability to meet customer requirements is critical during any supply chain disruption. This will provide companies with a competitive advantage and allow the business to continue.
     
    CP: What’s the outlook for the supply chain until the pandemic ends?
     
    VC: Because of our team’s operational diligence throughout the pandemic, Dr. Reddy’s is in a strong position. Its global supply chain team continues to work with our external partners and internal cross functional teams to drive the manufacturing and product supply for our customers. The outlook remains positive as we improve our capabilities and deliver value to our customers and patients. This done through continuous focus, vigilance and maintaining the patient-centric approach.
     
    CP: To what extent can lessons learned from the disruption be applied to your supply chain management in the future?
     
    VC:
    The lessons learned are invaluable to manage the supply chain and also to improve it on a sustained basis going forward in the future. Constant communication, coordination and diligence between Dr. Reddy’s Supply Chain Management with our internal cross functional teams along with our many CMOs, CPOs and vendors will always drive the business.
     
    It is critical that Dr. Reddy’s executes its materials management plan and maintains adequate safety stocks of API’s and finished goods to specific pre-determined levels to avoid supply disruptions. For API suppliers, it is critical for them to maintain adequate levels of KSMs and APIs. Alignment with the 3PL is critical so product shipments can be made to the customers on time and in full. 
     
    Dr. Reddy’s developed the outbound logistics and product supply strategy and followed the game plan consistently. It is vital to communicate, and over communicate, the action plans and expectations to the teams so everyone is aligned. The use of technology and digital tools is invaluable when conducting business and keeping our people connected during challenging times. The technology will continue to be leveraged to add value.
     
    In conclusion, we will continue to drive excellence across the manufacturing and supply chains to consistently deliver products to meet the needs of our customers and our patients.


    Vincent Colicchio has over 30 years of manufacturing, supply chain and operations management experience with increasing responsibility in the pharmaceutical manufacturing industry. Experienced operations executive with the ability to provide leadership and vision to successfully execute supply chain strategies to manufacture, package and distribute high quality pharmaceutical Generics and Rx products; direct production planning, materials management and logistics; coordinate technical transfers for full-scale commercial manufacturing and new product launches; provide commercial support to sales and marketing; supervise the design and completion of engineering and facilities projects; establish and implement budget control; and administer cGMP/Regulatory/EHS compliance regulations to achieve the corporate goals.
    Suggested For You
    Bora Pharmaceuticals Bora Pharmaceuticals
    Legacy Pharma Solutions Legacy Pharma Solutions
    Taros Chemicals GmbH & Co. KG Taros Chemicals GmbH & Co. KG
    Vio Chemicals Vio Chemicals
    W. R. Grace FCMS W. R. Grace FCMS
    WuXi AppTec WuXi AppTec
    PCI Pharma Services PCI Pharma Services
    Sekisui Sekisui
    NGT BioPharma Consultants, LLC NGT BioPharma Consultants, LLC
    PCI Synthesis PCI Synthesis
    Seqens CDMO North America Seqens CDMO North America
    pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray
    Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany
    Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate  Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate
    Clean Cells Expands Bioproduction Capabilities Clean Cells Expands Bioproduction Capabilities

    Related Buyers Guide Companies

    • Bora Pharmaceuticals

      Bora Pharmaceuticals

      ...
      Lonnie Barish, VP, Business Development 03.09.22

    • Legacy Pharma Solutions

      Legacy Pharma Solutions

      ...
      Nathan Bender, Director, Sales & Marketing 12.07.21

    • Taros Chemicals GmbH & Co. KG

      ...
      Dimitrios Tzalis, Manager Executive Projects 12.07.21


    • Vio Chemicals

      ...
      Ioanna Kazantzidou, Marketing Communications Officer 12.07.21

    • W. R. Grace FCMS

      W. R. Grace FCMS

      ...
      Stella Ip, Director Marketing Health and Life Sciences 11.23.21

    Loading, Please Wait..
    Trending
    • Almac Invests $65M To Expand North American HQ
    • Just – Evotec Biologics And Alpine Immune Sciences Expand Partnership
    • West Pharmaceutical Makes Strategic Investment In Latch Medical
    • AskBio Appoints Clinical Ops Executives
    • Catalent To Acquire Metrics Contract Services For $475M
    Breaking News
    • AskBio Appoints Clinical Ops Executives
    • GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    • SpectrumX Partners With UK Contract Manufacturer
    • Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership
    • Almac Invests $65M to Expand North American HQ
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Biotechnology’s Role in Improving Stroke Outcomes
    • CEO Spotlight: Marc Kikuchi
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Coatings World

    Latest Breaking News From Coatings World

    What are you Reading this Week?
    SONGWON Industrial Group Reports Strong Q2 Financial Results
    PPG Completes COLORFUL COMMUNITIES Project for Boys & Girls Clubs of Greater Houston
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Aug. 13
    'Graft-on-a-Chip' Built to Improve Vascular Graft Success
    Abbott Invests €440 in New Irish Facility
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AskBio Appoints Clinical Ops Executives
    SpectrumX Partners With UK Contract Manufacturer
    GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Arkay Chairman Emeritus Howard Kaneff Has Died
    Nutricosmetics Market to Hit $13.7 Billion by 2030
    Estée Lauder Pledges 100% Electric Fleet of Vehicles by 2030
    Happi

    Latest Breaking News From Happi

    Consumers are Clamoring for Vintage Glam: Spate
    Kayali’s Lovefest Fragrance, Newell’s New Candle and HydraFacial’s Record Financial Results
    Self Care Trumps Home Care Post-Covid
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Printing Ink Primer, Zeller+Gmelin Lead This Week’s News Stories
    Heidelberg Enjoys Successful Start to 2022-23 Fiscal Year
    Mimaki Announces New LATAM Website
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Esko, Constantia Flexibles announce acquisitions and more
    Hybrid Software joins The Flexo Xperience Center
    Flexo Wash LLC and Mike Potter celebrate 20 years
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: Essity Switches to Recyclable Packs for Feminine Pads, FTC Sues PPE Maker on False Origin Claims & More
    Focke & Co. to Host Destination: Your Hygiene Hub on August 31
    Exports Dominate Chinese Trade of Tissues, Hygiene Products and Wipes
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Aug. 13
    Dental 3D Printing Market is Expanding 20% Annually
    Study Results Released for Abbott's Concussion Blood Test
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: ALTANA, Universal Display and Emerson Top This Week’s Stories
    eMagin Corporation Announces 2Q 2022 Results
    Zebra Technologies’ Emission Reduction Targets Validated by SBTi

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login